Basic Information
| RNALocate ID: | RLID:11002341 |
| RNA Symbol: | hsa-miR-29c-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-29c |
| RNA ID: | miRBase:MIMAT0000681 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001983 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001984 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001985 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11002331 | Exosome | Serum | 18589210 |
| RLID:11002332 | Exosome | Saliva | 19627513 |
| RLID:11002333 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002334 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002335 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002336 | Exosome | Breast milk | 22211110 |
| RLID:11002337 | Exosome | Brain tissue | 23382797 |
| RLID:11002338 | Exosome | Plasma | 23663360 |
| RLID:11002339 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002340 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002342 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000108 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid | |
| RLID-D:11000395 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29c-3p | Diffuse large b cell lymphoma | MNDR-E-MI-35448 |
| MNDR | hsa-miR-29c-3p | Splenic marginal zone lymphoma | MNDR-E-MI-35449 |
| MNDR | hsa-miR-29c-3p | Oral squamous cell carcinoma | MNDR-E-MI-35450 |
| MNDR | hsa-miR-29c-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35451 |
| MNDR | hsa-miR-29c-3p | B cell lymphoma of malt type | MNDR-E-MI-35452 |
| MNDR | hsa-miR-29c-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-35453 |
| MNDR | hsa-miR-29c-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35454 |
| MNDR | hsa-miR-29c-3p | Ovarian clear cell carcinoma | MNDR-E-MI-35455 |
| MNDR | hsa-miR-29c-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35456 |
| MNDR | hsa-miR-29c-3p | Lymphoma | MNDR-E-MI-35457 |
| MNDR | hsa-miR-29c-3p | Lymphoma non-hodgkin | MNDR-E-MI-35458 |
| MNDR | hsa-miR-29c-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35459 |
| MNDR | hsa-miR-29c-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35460 |
| MNDR | hsa-miR-29c-3p | Breast cancer luminal b | MNDR-E-MI-35461 |
| MNDR | hsa-miR-29c-3p | Niemann-pick disease type c | MNDR-E-MI-35462 |
| MNDR | hsa-miR-29c-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-35463 |
| MNDR | hsa-miR-29c-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-35464 |
| MNDR | hsa-miR-29c-3p | Small intestine cancer | MNDR-E-MI-35465 |
| MNDR | hsa-miR-29c-3p | Dermatomyositis | MNDR-E-MI-35466 |
| MNDR | hsa-miR-29c-3p | Prostate cancer | MNDR-E-MI-35467 |
| MNDR | hsa-miR-29c-3p | Gastric cancer | MNDR-E-MI-35468 |
| MNDR | hsa-miR-29c-3p | Gastric lymphoma | MNDR-E-MI-35469 |
| MNDR | hsa-miR-29c-3p | Alzheimer disease | MNDR-E-MI-35470 |
| MNDR | hsa-miR-29c-3p | Intracranial aneurysm | MNDR-E-MI-35471 |
| MNDR | hsa-miR-29c-3p | Urinary bladder cancer | MNDR-E-MI-35472 |
| MNDR | hsa-miR-29c-3p | Esophageal carcinoma | MNDR-E-MI-35473 |
| MNDR | hsa-miR-29c-3p | Dysautonomia familial | MNDR-E-MI-35474 |
| MNDR | hsa-miR-29c-3p | Myotonic dystrophy | MNDR-E-MI-35475 |
| MNDR | hsa-miR-29c-3p | Duchenne muscular dystrophy | MNDR-E-MI-35476 |
| MNDR | hsa-miR-29c-3p | Head and neck cancer | MNDR-E-MI-35477 |
| MNDR | hsa-miR-29c-3p | Leukemia | MNDR-E-MI-35478 |
| MNDR | hsa-miR-29c-3p | Huntington disease | MNDR-E-MI-35479 |
| MNDR | hsa-miR-29c-3p | Cardiovascular disease | MNDR-E-MI-35480 |
| MNDR | hsa-miR-29c-3p | Moyamoya disease | MNDR-E-MI-35481 |
| MNDR | hsa-miR-29c-3p | Uterine fibroid | MNDR-E-MI-35482 |
| MNDR | hsa-miR-29c-3p | Lung cancer | MNDR-E-MI-35483 |
| MNDR | hsa-miR-29c-3p | Down syndrome | MNDR-E-MI-35484 |
| MNDR | hsa-miR-29c-3p | Parkinson disease | MNDR-E-MI-35485 |
| MNDR | hsa-miR-29c-3p | Niemann-pick disease | MNDR-E-MI-35486 |
| MNDR | hsa-miR-29c-3p | Breast cancer | MNDR-E-MI-35487 |
| MNDR | hsa-miR-29c-3p | Thyroid cancer | MNDR-E-MI-35488 |
| MNDR | hsa-miR-29c-3p | Pancreatic cancer | MNDR-E-MI-35489 |
| MNDR | hsa-miR-29c-3p | HCV | MNDR-E-MI-35490 |
| MNDR | hsa-miR-29c-3p | Melanoma | MNDR-E-MI-35491 |
| MNDR | hsa-miR-29c-3p | Rectum adenocarcinoma | MNDR-E-MI-35492 |
| MNDR | hsa-miR-29c-3p | Nephroblastoma | MNDR-E-MI-35493 |
| MNDR | hsa-miR-29c-3p | Colon cancer | MNDR-E-MI-35494 |
| MNDR | hsa-miR-29c-3p | Ischemic attack transient | MNDR-E-MI-35495 |
| MNDR | hsa-miR-29c-3p | Colon adenocarcinoma | MNDR-E-MI-35496 |
| MNDR | hsa-miR-29c-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35497 |
| MNDR | hsa-miR-29c-3p | Familial ovarian cancer | MNDR-E-MI-35498 |
| MNDR | hsa-miR-29c-3p | Prostate adenocarcinoma | MNDR-E-MI-35499 |
| MNDR | hsa-miR-29c-3p | Kidney cancer | MNDR-E-MI-35500 |
| MNDR | hsa-miR-29c-3p | Endometriosis | MNDR-E-MI-35501 |
| MNDR | hsa-miR-29c-3p | Thyroid adenomas | MNDR-E-MI-35502 |
| MNDR | hsa-miR-29c-3p | Invasive ductal carcinoma | MNDR-E-MI-35503 |
| MNDR | hsa-miR-29c-3p | Glioblastoma | MNDR-E-MI-35504 |
| MNDR | hsa-miR-29c-3p | Astrocytoma | MNDR-E-MI-35505 |
| MNDR | hsa-miR-29c-3p | Glioma | MNDR-E-MI-35506 |
| MNDR | hsa-miR-29c-3p | Nemaline myopathy | MNDR-E-MI-35507 |
| MNDR | hsa-miR-29c-3p | Peripheral nerve sheath tumours | MNDR-E-MI-35508 |
| MNDR | hsa-miR-29c-3p | Central nervous system lymphoma | MNDR-E-MI-35509 |
| MNDR | hsa-miR-29c-3p | Rhabdomyosarcoma | MNDR-E-MI-35510 |
| MNDR | hsa-miR-29c-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35511 |
| MNDR | hsa-miR-29c-3p | Epilepsy temporal lobe | MNDR-E-MI-35512 |
| MNDR | hsa-miR-29c-3p | Osteosarcoma | MNDR-E-MI-35513 |
| MNDR | hsa-miR-29c-3p | Liposarcoma | MNDR-E-MI-35514 |
| MNDR | hsa-miR-29c-3p | Inclusion body myositis | MNDR-E-MI-35515 |
| MNDR | hsa-miR-29c-3p | Meningioma | MNDR-E-MI-35516 |
| MNDR | hsa-miR-29c-3p | Gastric adenocarcinoma | MNDR-E-MI-35517 |
| MNDR | hsa-miR-29c-3p | Cervical squamous cell carcinoma | MNDR-E-MI-35518 |
| MNDR | hsa-miR-29c-3p | Lung squamous cell carcinoma | MNDR-E-MI-35519 |
| MNDR | hsa-miR-29c-3p | Adrenocortical carcinoma | MNDR-E-MI-35520 |
| MNDR | hsa-miR-29c-3p | Thyroid carcinoma | MNDR-E-MI-35521 |
| MNDR | hsa-miR-29c-3p | Papillary thyroid carcinoma | MNDR-E-MI-35522 |
| MNDR | hsa-miR-29c-3p | Ovarian carcinoma | MNDR-E-MI-35523 |
| MNDR | hsa-miR-29c-3p | Bladder urothelial carcinoma | MNDR-E-MI-35524 |
| MNDR | hsa-miR-29c-3p | Brain stem cancer | MNDR-E-MI-35525 |
| MNDR | hsa-miR-29c-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-35526 |
| MNDR | hsa-miR-29c-3p | Carcinoma renal cell | MNDR-E-MI-35527 |
| MNDR | hsa-miR-29c-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35528 |
| MNDR | hsa-miR-29c-3p | Renal clear cell carcinoma | MNDR-E-MI-35529 |
| MNDR | hsa-miR-29c-3p | Cholangiocarcinoma | MNDR-E-MI-35530 |
| MNDR | hsa-miR-29c-3p | Esophageal cancer | MNDR-E-MI-35531 |
| MNDR | hsa-miR-29c-3p | Lung small cell carcinoma | MNDR-E-MI-35532 |
| MNDR | hsa-miR-29c-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35533 |
| MNDR | hsa-miR-29c-3p | Testicular germ cell cancer | MNDR-E-MI-35534 |
| MNDR | hsa-miR-29c-3p | T acute lymphoblastic leukemia | MNDR-E-MI-35535 |
| MNDR | hsa-miR-29c-3p | HBV+ hepatocellular carcinoma | MNDR-E-MI-35536 |
| MNDR | hsa-miR-29c-3p | Familiar ovarian carcinoma | MNDR-E-MI-35537 |
| MNDR | hsa-miR-29c-3p | Aggressive b-cell lymphoma | MNDR-E-MI-35538 |
| MNDR | hsa-miR-29c-3p | Rheumatoid arthritis | MNDR-E-MI-35539 |
| MNDR | hsa-miR-29c-3p | T-cell leukemia | MNDR-E-MI-35540 |
| MNDR | hsa-miR-29c-3p | Retinoblastoma | MNDR-E-MI-35541 |
| MNDR | hsa-miR-29c-3p | Neuroblastoma | MNDR-E-MI-35542 |
| MNDR | hsa-miR-29c-3p | Barrett's adenocarcinoma | MNDR-E-MI-35543 |
| MNDR | hsa-miR-29c-3p | Chronic myelogenous leukemia | MNDR-E-MI-35544 |
| MNDR | hsa-miR-29c-3p | Hodgkin lymphoma | MNDR-E-MI-35545 |
| MNDR | hsa-miR-29c-3p | Burkitt lymphoma | MNDR-E-MI-35546 |
| MNDR | hsa-miR-29c-3p | Tonsil cancer | MNDR-E-MI-35547 |
| MNDR | hsa-miR-29c-3p | Skin cutaneous melanoma | MNDR-E-MI-35548 |
| MNDR | hsa-miR-29c-3p | Skin melanoma | MNDR-E-MI-35549 |
| MNDR | hsa-miR-29c-3p | Colorectal cancer | MNDR-E-MI-35550 |
| MNDR | hsa-miR-29c-3p | Nasopharyngeal carcinoma | MNDR-E-MI-35551 |
| MNDR | hsa-miR-29c-3p | Type 2 diabetes mellitus | MNDR-E-MI-35552 |
| MNDR | hsa-miR-29c-3p | Multiple myeloma | MNDR-E-MI-35553 |
| MNDR | hsa-miR-29c-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-35554 |
| MNDR | hsa-miR-29c-3p | Ependymoma | MNDR-E-MI-35555 |
| MNDR | hsa-miR-29c-3p | Cardiomegaly | MNDR-E-MI-35556 |
| MNDR | hsa-miR-29c-3p | Nasopharyngeal cancer | MNDR-E-MI-35557 |
| MNDR | hsa-miR-29c-3p | Prostatic neoplasms | MNDR-E-MI-35558 |
| MNDR | hsa-miR-29c-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-35559 |
| MNDR | hsa-miR-29c-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35560 |
| MNDR | hsa-miR-29c-3p | Sarcopenia | MNDR-E-MI-35561 |
| MNDR | hsa-miR-29c-3p | Stroke lacunar | MNDR-E-MI-35562 |
| MNDR | hsa-miR-29c-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-35563 |
| MNDR | hsa-miR-29c-3p | Barrett's carcinogenesis | MNDR-E-MI-35564 |
| MNDR | hsa-miR-29c-3p | HPV | MNDR-E-MI-35565 |
| MNDR | hsa-miR-29c-3p | Low grade dysplastic nodule | MNDR-E-MI-35566 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM12 | Homo sapiens | RR00040365 |
TOP